Health & Medicine

• Health & Medicine

First immunotherapy approved for cervical cancer in England and Scotland

The immunotherapy pembrolizumab may help some people with incurable cervical cancer live longer. It's now an approved treatment for them in England and Scotland. The immunotherapy pembrolizumab may help some people with incurable cervical cancer live longer. It's now an approved treatment for them in England and Scotland.

16 May 2023

• Health & Medicine
• Policy & Insight

People who’ve had radiotherapy shape our new policy calls

On the back of a recent survey, our new policy position statement on radiotherapy turns patient experiences into recommendations for the Government and the NHS. On the back of a recent survey, our new policy position statement on radiotherapy turns patient experiences into recommendations for the Government and the NHS.

4 May 2023

• Health & Medicine

Severe mental illness linked to low attendance at cancer screening

New research has found that adults with severe mental illness are less likely to attend cancer screening than those who do not have such conditions. New research has found that adults with severe mental illness are less likely to attend cancer screening than those who do not have such conditions.

4 May 2023

• Health & Medicine

How longer waiting times are impacting teens and young adults

Concluding our first Teenager and Young Adult Cancer Awareness Month, we look at how longer waiting times are impacting their mental health. Concluding our first Teenager and Young Adult Cancer Awareness Month, we look at how longer waiting times are impacting their mental health.

27 April 2023

• Health & Medicine

FOCUS4: Learning from a landmark clinical trial

FOCUS4 was a large-scale trial investigating new treatments in people with advanced or metastatic colorectal cancer. Running it may not have been without its challenges, but the learnings it provided us with are invaluable if we're to run trials like it again.  FOCUS4 was a large-scale trial investigating new treatments in people with advanced or metastatic colorectal cancer. Running it may not have been without its challenges, but the learnings it provided us with are invaluable if we're to run trials like it again. 

25 April 2023

• Health & Medicine

Our 10 top tips to help you talk about cancer

Talking about cancer can save lives and help to break down the barriers people may face to seeking help. We know that talking about cancer isn’t easy, but we want to help you with our 10 top tips Talking about cancer can save lives and help to break down the barriers people may face to seeking help. We know that talking about cancer isn’t easy, but we want to help you with our 10 top tips

24 April 2023

• Health & Medicine

Routes to a healthier shopping journey – how your supermarket environment influences what goes into your basket

In partnership with British Heart Foundation and Diabetes UK, we have released our new Trolley Trends analysis which explores attitudes and behaviours around healthy eating and food shopping In partnership with British Heart Foundation and Diabetes UK, we have released our new Trolley Trends analysis which explores attitudes and behaviours around healthy eating and food shopping

20 April 2023

• Science & Technology
• Health & Medicine

3 ways we're helping teenagers and young adults with cancer

Teenagers and young adults with cancer have to deal with unique challenges. We're using our expertise to help tackle them. Teenagers and young adults with cancer have to deal with unique challenges. We're using our expertise to help tackle them.

18 April 2023

• Health & Medicine
• Policy & Insight

The UK Government's response to Javed Khan's tobacco review: A small step in the right direction, but much more action is needed

While today's speech from Neil O'Brien MP was a welcome positive first step in the right direction, the UK Government has missed a key opportunity to get us back on track to achieving a Smokefree 2030 While today's speech from Neil O'Brien MP was a welcome positive first step in the right direction, the UK Government has missed a key opportunity to get us back on track to achieving a Smokefree 2030

11 April 2023

• Health & Medicine

Olaparib approved for 800 prostate and breast cancer patients in England

Olaparib, a targeted cancer drug discovered and developed with our funding, has been approved for hundreds of patients with certain breast and prostate cancers in England.  Olaparib, a targeted cancer drug discovered and developed with our funding, has been approved for hundreds of patients with certain breast and prostate cancers in England. 

11 April 2023

• Health & Medicine

Children’s cancer charities team up for tomorrow’s treatments

We're helping treble funding for paediatric Experimental Cancer Medicine Centres, paving the way to more effective and less toxic treatments for children and young people. We're helping treble funding for paediatric Experimental Cancer Medicine Centres, paving the way to more effective and less toxic treatments for children and young people.

3 April 2023